173
Views
0
CrossRef citations to date
0
Altmetric
Epidemiology

Clinical epidemiology of amyotrophic lateral sclerosis in Liguria, Italy: a ten year follow up study

ORCID Icon, , , , , , , , , , , , & show all
Pages 104-111 | Received 03 Jul 2023, Accepted 07 Sep 2023, Published online: 22 Sep 2023

References

  • Phukan J, Elamin M, Bede P, Jordan N, Gallagher L, Byrne S, et al. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry. 2012;83:102–8.
  • Montuschi A, Iazzolino B, Calvo A, Moglia C, Lopiano L, Restagno G, et al. Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy. J Neurol Neurosurg Psychiatry. 2015;86:168–73.
  • Renton AE, Chio `A, Traynor BJ. State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci. 2014;17:17–23.
  • Chiò A, Logroscino G, Traynor BJ, Collins J, Simeone JC, Goldstein LA, et al. Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology 2013;41:118–30.
  • Zoccolella S, Beghi E, Palagano G, Fraddosio A, Guerra V, Lepore V, et al. ALS multidisciplinary clinic and survival: results from a population-based study in Southern Italy. J Neurol. 2007;254:1107–12.
  • Turner MR, Bakker M, Sham P, Shaw CE, Leigh PN, Al-Chalabi A. Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2002;3:15–21.
  • Bandettini di Poggio M, Sormani MP, Truffelli R, Mandich P, Origone P, Verdiani S, et al. Clinical epidemiology of ALS in Liguria, Italy. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:52–7.
  • Scialò C, Novi G, Bandettini di Poggio M, Canosa A, Sormani MP, Mandich P, et al. Clinical epidemiology of amyotrophic lateral sclerosis in Liguria, Italy: an update of LIGALS register. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17:535–42.
  • Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
  • Woodward M. Epidemiology: study design and data analysis. Boca Raton: Chapman and Hall/CRC Press; 1999:159–67.
  • Chiò A, Mora G, Calvo A, Mazzini L, Bottacchi E, Mutani R. Epidemiology of ALS in Italy: a 10-years prospective population based study. Neurology 2009;72:725–31.
  • Logroscino G, Beghi E, Zoccolella S, Palagano R, Fraddosio A, Simone IL, et al. Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study. J Neurol Neurosurg Psychiatry. 2005;76:1094–8.
  • Beghi E, Millul A, Micheli A, Vitelli E, Logroscino G. Incidence of amyotrophic lateral sclerosis in Lombardy, Italy. Neurology 2007;68:141–5.
  • Ragonese P, Cellura E, Aridon P, D'amelio M, Spataro R, Taiello AC, et al. Incidence of amyotrophic lateral sclerosis in Sicily: a population based study. Amyotroph Lateral Scler. 2012;13:284–7.
  • Mandrioli J, Biguzzi S, Guidi C, Venturini E, Sette E, Terlizzi E, et al. Epidemiology of amyotrophic lateral sclerosis in Emilia Romagna Region (Italy): a population based study. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:262–8.
  • Palese F, Sartori A, Verriello L, Ros S, Passadore P, Manganotti P, et al. Epidemiology of amyotrophic lateral sclerosis in Friuli-Venezia Giulia, North-Eastern Italy, 2002–2014: a retrospective population-based study. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:90–9.
  • Schoemberg BS. Calculating confidence intervals for rates and ratios. Neuroepidemiology 1983;2:257–65.
  • Chiò A, Mora G, Moglia C, Manera U, Canosa A, Cammarosano S, et al. Secular trends of amyotrophic lateral sclerosis the Piemonte and Valle d’Aosta register. JAMA Neurol. 2017;74:1097–104.
  • Gianferrari G, Martinelli I, Zucchi E, Simonini C, Fini N, Vinceti M, et al. Epidemiological, clinical and genetic features of ALS in the last decade: a prospective population-based study in the Emilia Romagna Region of Italy. Biomedicines 2022;10:819.
  • Chiò A, Mora G, Leone M, Mazzini L, Cocito D, Giordana MT, et al. Early symptom progression rate is related to ALS outcome: a prospective population-based study. Neurology 2002;59:99–103.
  • Pupillo E, Messina P, Logroscino G, Beghi E. Long-term survival in amyotrophic lateral sclerosis: a population based study. Ann Neurol. 2014;75:287–97.
  • Ferraro PM, Cabona C, Meo G, Rolla-Bigliani C, Castellan L, Pardini M, et al. Age at symptom onset influences cortical thinning distribution and survival in amyotrophic lateral sclerosis. Neuroradiology 2021;63:1481–7.
  • Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P, et al. EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) – revised report of an EFNS task force. Eur J Neurol. 2012;19:360–75.
  • Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, et al. Practice Parameter update: The care of the patient with amyotrophic lateral sclerosis: Drug, nutritional, and respiratory therapies (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2009;73:1218–26.
  • Burkhardt C, Neuwirth C, Sommacal A, Andersen PM, Weber M. Is survival improved by the use of NIV and PEG in amyotrophic lateral sclerosis (ALS)? A post-mortem study of 80 ALS patients. PLOS One. 2017;12:e0177555.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.